Quantbot Technologies LP Bio Atla, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.3 - $8.25 $11,157 - $40,020	4,851 New	4,851 $13,000
Q2 2022 Aug 09, 2022	SELL	$2.13 - $5.38 $17,359 - $43,847	-8,150 Reduced 77.55%	2,359 $6,000
Q1 2022 May 16, 2022	BUY	$4.38 - $18.78 $27,195 - $116,605	6,209 Added 144.4%	10,509 $52,000
Q4 2021 Feb 11, 2022	BUY	$19.0 - $30.95 $81,700 - $133,085	4,300 New	4,300 $84,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.